Douglas Pharmaceuticals Announces Formation of Clinical Advisory Board for Lead Program R-107 ...Middle East

PR Newswire - News
Douglas Pharmaceuticals Announces Formation of Clinical Advisory Board for Lead Program R-107
AUCKLAND, New Zealand, Jan. 26, 2023 /PRNewswire/ -- Douglas Pharmaceuticals, a New Zealand Pharmaceutical company focused on specialty generic and repurposed drug development, today announced the formation of a clinical advisory board to support its lead program R-107, an oral...

Hence then, the article about douglas pharmaceuticals announces formation of clinical advisory board for lead program r 107 was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Douglas Pharmaceuticals Announces Formation of Clinical Advisory Board for Lead Program R-107 )

Apple Storegoogle play

Last updated :

Also on site :